DE602006017220D1 - Ethanolaminsalz von n-(methoxy-5-methylpyrazin-2-yl)-2-(4-ä1,3,4-oxadiazol-2-ylüphenyl)pyridin-3-sulfonamid - Google Patents
Ethanolaminsalz von n-(methoxy-5-methylpyrazin-2-yl)-2-(4-ä1,3,4-oxadiazol-2-ylüphenyl)pyridin-3-sulfonamidInfo
- Publication number
- DE602006017220D1 DE602006017220D1 DE602006017220T DE602006017220T DE602006017220D1 DE 602006017220 D1 DE602006017220 D1 DE 602006017220D1 DE 602006017220 T DE602006017220 T DE 602006017220T DE 602006017220 T DE602006017220 T DE 602006017220T DE 602006017220 D1 DE602006017220 D1 DE 602006017220D1
- Authority
- DE
- Germany
- Prior art keywords
- methylpyrazin
- oxadiazol
- pyridine
- methoxy
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0514743.4A GB0514743D0 (en) | 2005-07-19 | 2005-07-19 | Salt |
| PCT/GB2006/002654 WO2007010235A1 (en) | 2005-07-19 | 2006-07-17 | Ethanolamine salt of n- (3-methoxy-5-methylpyrazin-2yl) -2- (4- [1 , 3 , 4-0xadiaz0le-2-yl] phenyl) pyridine-3- sulphonamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006017220D1 true DE602006017220D1 (de) | 2010-11-11 |
Family
ID=34897419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006017220T Active DE602006017220D1 (de) | 2005-07-19 | 2006-07-17 | Ethanolaminsalz von n-(methoxy-5-methylpyrazin-2-yl)-2-(4-ä1,3,4-oxadiazol-2-ylüphenyl)pyridin-3-sulfonamid |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20080221124A1 (de) |
| EP (1) | EP1904490B1 (de) |
| JP (1) | JP5085544B2 (de) |
| KR (1) | KR20080031042A (de) |
| CN (1) | CN101223165B (de) |
| AT (1) | ATE482952T1 (de) |
| AU (1) | AU2006271420B2 (de) |
| CA (1) | CA2615596A1 (de) |
| CY (1) | CY1110942T1 (de) |
| DE (1) | DE602006017220D1 (de) |
| DK (1) | DK1904490T3 (de) |
| ES (1) | ES2351442T3 (de) |
| GB (1) | GB0514743D0 (de) |
| HK (1) | HK1118276A1 (de) |
| HR (1) | HRP20100621T1 (de) |
| IL (1) | IL188389A0 (de) |
| MX (1) | MX2008000889A (de) |
| NO (1) | NO20080053L (de) |
| PL (1) | PL1904490T3 (de) |
| PT (1) | PT1904490E (de) |
| SI (1) | SI1904490T1 (de) |
| WO (1) | WO2007010235A1 (de) |
| ZA (1) | ZA200800328B (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0219660D0 (en) | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
| GB0403744D0 (en) | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
| GB0914287D0 (en) * | 2009-08-14 | 2009-09-30 | Pci Biotech As | Compositions |
| CN102491973A (zh) * | 2011-12-15 | 2012-06-13 | 南京友杰医药科技有限公司 | Zd-4054的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5464853A (en) * | 1993-05-20 | 1995-11-07 | Immunopharmaceutics, Inc. | N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5514691A (en) * | 1993-05-20 | 1996-05-07 | Immunopharmaceutics, Inc. | N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| UA58494C2 (uk) * | 1995-06-07 | 2003-08-15 | Зенека Лімітед | Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну |
| US20020055457A1 (en) * | 2000-08-07 | 2002-05-09 | Janus Todd J. | Methods of treating cancer and the pain associated therewith using endothelin antagonists |
| US20030092757A1 (en) * | 2001-04-11 | 2003-05-15 | Amitabh Singh | Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
| DE10155076A1 (de) * | 2001-11-09 | 2003-05-22 | Merck Patent Gmbh | Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen |
| ATE312096T1 (de) * | 2001-12-18 | 2005-12-15 | Neue verbindungen | |
| GB0219660D0 (en) * | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
-
2005
- 2005-07-19 GB GBGB0514743.4A patent/GB0514743D0/en not_active Ceased
-
2006
- 2006-07-17 PL PL06755779T patent/PL1904490T3/pl unknown
- 2006-07-17 PT PT06755779T patent/PT1904490E/pt unknown
- 2006-07-17 CN CN2006800261471A patent/CN101223165B/zh not_active Expired - Fee Related
- 2006-07-17 EP EP06755779A patent/EP1904490B1/de active Active
- 2006-07-17 SI SI200630823T patent/SI1904490T1/sl unknown
- 2006-07-17 MX MX2008000889A patent/MX2008000889A/es active IP Right Grant
- 2006-07-17 DE DE602006017220T patent/DE602006017220D1/de active Active
- 2006-07-17 AT AT06755779T patent/ATE482952T1/de active
- 2006-07-17 ES ES06755779T patent/ES2351442T3/es active Active
- 2006-07-17 WO PCT/GB2006/002654 patent/WO2007010235A1/en active Application Filing
- 2006-07-17 KR KR1020087002607A patent/KR20080031042A/ko not_active Application Discontinuation
- 2006-07-17 US US11/996,005 patent/US20080221124A1/en not_active Abandoned
- 2006-07-17 JP JP2008522051A patent/JP5085544B2/ja not_active Expired - Fee Related
- 2006-07-17 CA CA002615596A patent/CA2615596A1/en not_active Abandoned
- 2006-07-17 AU AU2006271420A patent/AU2006271420B2/en not_active Ceased
- 2006-07-17 DK DK06755779.3T patent/DK1904490T3/da active
-
2007
- 2007-12-24 IL IL188389A patent/IL188389A0/en unknown
-
2008
- 2008-01-04 NO NO20080053A patent/NO20080053L/no not_active Application Discontinuation
- 2008-01-10 ZA ZA200800328A patent/ZA200800328B/xx unknown
- 2008-08-21 HK HK08109379.4A patent/HK1118276A1/xx not_active IP Right Cessation
-
2010
- 2010-11-16 HR HR20100621T patent/HRP20100621T1/hr unknown
- 2010-11-25 CY CY20101101068T patent/CY1110942T1/el unknown
-
2011
- 2011-07-25 US US13/189,818 patent/US20120101109A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP5085544B2 (ja) | 2012-11-28 |
| SI1904490T1 (sl) | 2010-12-31 |
| IL188389A0 (en) | 2008-04-13 |
| AU2006271420B2 (en) | 2010-09-23 |
| MX2008000889A (es) | 2008-03-18 |
| CY1110942T1 (el) | 2015-06-10 |
| ATE482952T1 (de) | 2010-10-15 |
| DK1904490T3 (da) | 2010-12-13 |
| WO2007010235A8 (en) | 2008-03-13 |
| AU2006271420A1 (en) | 2007-01-25 |
| PT1904490E (pt) | 2010-11-18 |
| CA2615596A1 (en) | 2007-01-25 |
| HRP20100621T1 (hr) | 2010-12-31 |
| WO2007010235A1 (en) | 2007-01-25 |
| ZA200800328B (en) | 2008-12-31 |
| NO20080053L (no) | 2008-04-16 |
| CN101223165B (zh) | 2011-10-19 |
| KR20080031042A (ko) | 2008-04-07 |
| EP1904490B1 (de) | 2010-09-29 |
| EP1904490A1 (de) | 2008-04-02 |
| PL1904490T3 (pl) | 2011-02-28 |
| GB0514743D0 (en) | 2005-08-24 |
| US20080221124A1 (en) | 2008-09-11 |
| HK1118276A1 (en) | 2009-02-06 |
| CN101223165A (zh) | 2008-07-16 |
| ES2351442T3 (es) | 2011-02-04 |
| US20120101109A1 (en) | 2012-04-26 |
| JP2009501774A (ja) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201000145A1 (ru) | Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида | |
| EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
| CY1111752T1 (el) | Πυρρολοπυραζολες, δυναμικοι αναστολεις κινασης | |
| HRP20090229T1 (en) | Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl] phenyl)pyridine-3-sulphonamide and a biphosphonate | |
| EA200601568A1 (ru) | Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4 | |
| EA200601587A1 (ru) | Новые амидозамещённые гидрокси-6-фенилфенантридины | |
| CY1110026T1 (el) | Ενωσεις πιπεραζινης βενζισοξαζολης και μεθοδοι χρησης εξ αυτων | |
| RS50660B (sr) | Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže | |
| EA200801291A1 (ru) | Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ | |
| EA200701840A1 (ru) | N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы | |
| EA200900781A1 (ru) | 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды | |
| EA201000888A1 (ru) | 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов | |
| EA200801413A1 (ru) | Гетероциклические сетр ингибиторы | |
| ATE471324T1 (de) | Triazolophthalazine | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| EA200801351A1 (ru) | Фунгицидные смеси, которые содержат боскалид и пириметанил | |
| EA200702175A1 (ru) | Синергические фунгицидные комбинации биологически активных веществ | |
| CY1112433T1 (el) | Συνθεση ζιμποτεντανης που περιεχει μαννιτολη και μικροκρυσταλλικη κυτταρινη | |
| EA200601855A1 (ru) | Гербицидоактивные 3-амино-2-тиометилбензоилпиразолы | |
| IS2473B (is) | Samsetning sem inniheldur N-(3-metoxý-5-metýlpýrasín-2-ýl)-2-(4-(1,3,4-oxadíasól-2-ýl)fenýl)pýridín-3-súlfónamíð (ZD4054), eða lyfjafræðilega viðurkennt salt þess, og EGFR TKI, eða lyfjafræðilega viðurkennt salt þess | |
| CY1110942T1 (el) | Αλας αιθανολαμινης n-(3-μεθοξυ-αιθοξυ-5-μεθυλπυραζιν-2-υλ)-2-(4-[1,3,4-οξαδιαζολο -2-υλ]φαινυλ)πυριδινο-3-σουλφοναμιδιου | |
| CY1111432T1 (el) | Τετραϋδροκινολινες για χρηση ως διαμορφωτες της μιτοτικης κινητικης πρωτεϊνης eg5 | |
| NO20064793L (no) | Anvendelse av N-(2-arylpropionyl) sulfonamider for behandling av ryggmargskade. | |
| NO20072303L (no) | Kombinasjon av N-(3-metoksy-5-metylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazo 1-2-yl]fenyl)pyridin-3-sulfonamid og et mitotisk middel for behandling av kreft. | |
| CY1114511T1 (el) | Καρβονυλαμινο πυρρολοπυραζολες, ικανοι αναστολεις κινασων |